Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cindy Neuzillet

Showing results (31-40 of 138) with videos related to

Pageof 14
Sort By:
Cancers|November 11, 2022
Physical Activity as the Best Supportive Care in Cancer: The Clinician's and the Researcher's PerspectivesCécile Torregrosa, Frédéric Chorin, Eva Ester Molina Beltran, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2022
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?Gael S Roth, Cindy Neuzillet, Matthieu Sarabi, et al.
Case Reports in Gastroenterology|June 1, 2012
Prolonged survival in a patient with neuroendocrine tumor of the cecum and diffuse peritoneal carcinomatosisLouis de Mestier, Cindy Neuzillet, Olivia Hentic, et al.
Cancer Metastasis Reviews|May 22, 2013
Stromal expression of SPARC in pancreatic adenocarcinomaCindy Neuzillet, Annemilaï Tijeras-Raballand, Jérôme Cros, et al.
Journal for Immunotherapy of Cancer|December 1, 2019
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directionsMarc Hilmi, Cindy Neuzillet, Julien Calderaro, et al.
Bulletin Du Cancer|June 30, 2015
[Pancreatic adenocarcinoma: 10 years of progress]Pascal Hammel, Cindy Neuzillet, Sihem Bendaoud, et al.
Pharmacology & Therapeutics|May 20, 2023
Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?Matthieu Delaye, Adrien Rousseau, Léah Mailly-Giacchetti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 18, 2026
Toward precision chemotherapy in pancreatic ductal adenocarcinoma: molecular, transcriptomic and clinical determinantsGabriele Capurso, Ingrid Garajova, Cindy Neuzillet, et al.
Pharmacology & Therapeutics|October 15, 2013
MEK in cancer and cancer therapyCindy Neuzillet, Annemilaï Tijeras-Raballand, Louis de Mestier, et al.
JCO Global Oncology|November 5, 2020
Professional and Psychological Impacts of the COVID-19 Pandemic on Oncology Residents: A National SurveyMarc Hilmi, Alice Boilève, Anabelle Ducousso, et al.
Pageof 14

Showing results (31-40 of 138) with videos related to

Sort By:
Pageof 14
Cancers|November 11, 2022
Physical Activity as the Best Supportive Care in Cancer: The Clinician's and the Researcher's PerspectivesCécile Torregrosa, Frédéric Chorin, Eva Ester Molina Beltran, et al.
European Journal of Cancer (Oxford, England : 1990)|December 4, 2022
Cholangiocarcinoma: what are the options in all comers and how has the advent of molecular profiling opened the way to personalised medicine ?Gael S Roth, Cindy Neuzillet, Matthieu Sarabi, et al.
Case Reports in Gastroenterology|June 1, 2012
Prolonged survival in a patient with neuroendocrine tumor of the cecum and diffuse peritoneal carcinomatosisLouis de Mestier, Cindy Neuzillet, Olivia Hentic, et al.
Cancer Metastasis Reviews|May 22, 2013
Stromal expression of SPARC in pancreatic adenocarcinomaCindy Neuzillet, Annemilaï Tijeras-Raballand, Jérôme Cros, et al.
Journal for Immunotherapy of Cancer|December 1, 2019
Angiogenesis and immune checkpoint inhibitors as therapies for hepatocellular carcinoma: current knowledge and future research directionsMarc Hilmi, Cindy Neuzillet, Julien Calderaro, et al.
Bulletin Du Cancer|June 30, 2015
[Pancreatic adenocarcinoma: 10 years of progress]Pascal Hammel, Cindy Neuzillet, Sihem Bendaoud, et al.
Pharmacology & Therapeutics|May 20, 2023
Obesity, cancer, and response to immune checkpoint inhibitors: Could the gut microbiota be the mechanistic link?Matthieu Delaye, Adrien Rousseau, Léah Mailly-Giacchetti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|March 18, 2026
Toward precision chemotherapy in pancreatic ductal adenocarcinoma: molecular, transcriptomic and clinical determinantsGabriele Capurso, Ingrid Garajova, Cindy Neuzillet, et al.
Pharmacology & Therapeutics|October 15, 2013
MEK in cancer and cancer therapyCindy Neuzillet, Annemilaï Tijeras-Raballand, Louis de Mestier, et al.
JCO Global Oncology|November 5, 2020
Professional and Psychological Impacts of the COVID-19 Pandemic on Oncology Residents: A National SurveyMarc Hilmi, Alice Boilève, Anabelle Ducousso, et al.
Pageof 14